Updated: Jan 25, 2007
Description
Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is a rare autosomal dominant form of ectodermal dysplasia that affects the skin, sweat glands, nails, and teeth. The incidence is estimated to be 1 case in 2-4 million population. NFJ syndrome is entry 161000 in the Online Mendelian Inheritance in Man database. The syndrome is allelic to dermatopathia pigmentosa reticularis.
In 1927, Naegeli first described the syndrome as familiärer Chromatophoren-Naevus in a Swiss family. In 1954, Franceschetti and Jadassohn further analyzed the syndrome, as did Itin and colleagues in 1993.
NFJ syndrome is a reticulate pigmentary disorder. Other reticulate pigmentary diseases include X-linked reticulate pigmentary disorder, dermatopathia pigmentosa reticularis, Dowling-Degos disease, dyschromatosis, confluent and reticulated papillomatosis of Gougerot and Carteaud, and reticulated acropigmentation of Kitamura.
Differential diagnoses
Franceschetti and Jadassohn distinguished Naegeli syndrome from incontinentia pigmenti (Bloch-Sulzberger syndrome) by the equal frequency of the disorder in males and females and by the presence of palmar and plantar hyperkeratosis, hypohidrosis, and dental abnormalities. In contrast, incontinentia pigmenti is inherited as an X-linked dominant trait.
Hereditary bullous acrokeratotic poikiloderma of Weary-Kindler has some striking similarities to NFJ syndrome. However, hyperhidrosis is not reported with this entity, and dental abnormalities are only rarely observed (Larregue, 1981).
Changes in the rete ridges such as those in Dowling-Degos disease and amyloid deposition such as that in macular amyloidosis are not found in NFJ syndrome (Rebora, 1984; Tidman, 1987). Changes in hair follicles or apocrine ducts do not occur in NFJ syndrome; this observation excludes Fox-Fordyce disease (Arnold, 2000).
NFJ syndrome may be associated with a number of markers located in the vicinity of the type I keratin gene cluster on band 17q21 (see Causes).
NFJ syndrome is rare.
The estimated incidence is approximately 1 case in 2-4 million population.
Several families with this condition have been reported in Switzerland, Japan, Italy, and Greece (see Physical).
No sexual predilection is recognized.
Because of the inability to sweat, the disease is usually diagnosed early in life. The lack of fingerprint lines (ie, dermatoglyphics) can be easily checked.
In contrast, a highly significant linkage was detected with a number of markers located in the vicinity of the type I keratin gene cluster on band 17q21. With maximum 2-lod scores of 4.16 and 3.717 for the markers D17S1787 and D17S1886, respectively (Whittock, 2000). Hence, the genetic defect in this family is located between the microsatellite markers D17S798 and D17S957, which are separated by approximately 26.97 cM. However, the gene defect is still unknown. Other genes that encode differentiation-specific keratins such as the type I keratins K-15, K-19, and K-20; plakoglobin; and the MEOX1 gene have been excluded (Whittock, 2000).
The lack of dermatoglyphics is likely due to a defective protein that is involved in epithelial development and/or epithelial-mesenchymal interactions perhaps less likely due to the structure of the molecule. A number of candidate genes of this type have been mapped to the region critical to NFJ syndrome; these include the granulin gene that encodes a protein involved in epithelium growth and differentiation (Bhandari, 1992); frizzled homolog 2, a molecule involved in epithelial cell-signaling pathways (Zhao, 1995); ADAM-11, a protein implicated in cell-cell and cell-matrix interactions (Emi, 1993), and GRB-7, a membrane-bound growth factor receptor of uncertain function (Margolis, 1992); and the MEOX1 gene (Froehlich, 1999).
Dermatopathia Pigmentosa Reticularis
Dyskeratosis Congenita
Incontinentia Pigmenti
Pachyonychia Congenita
Reticulate Pigmented Anomaly
Acrokeratotic poikiloderma of Weary-Kindler
Acromelanosis progressiva
Dyschromia universalis hereditaria
Hidrotic ectodermal dysplasia
Hereditary bullous acrokeratotic poikiloderma
The histologic findings include slight hyperpigmentation of the basal layer and dermal melanophages. In addition, the variable occurrence of milia is described as part of the syndrome (Tzermias, 1995).
No treatment for this syndrome is effective.
Sports-related exercise should be restricted to only nonexhausting activities. In particular, patients with NFJ syndrome can be allowed to swim.
Arnold H, Odon R, James W. Andrews' Diseases of the Skin: Clinical Dermatology. 9th ed. Harcourt Brace & Co;2000:684.
Bhandari V, Bateman A. Structure and chromosomal location of the human granulin gene. Biochem Biophys Res Commun. Oct 15 1992;188(1):57-63. [Medline].
Emi M, Katagiri T, Harada Y, et al. A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nat Genet. Oct 1993;5(2):151-7. [Medline].
Engman MF. Congenital atrophy of the skin with reticular pigmentation. JAMA. 1935;103:1252-6.
Franceschetti A, Jadassohn W. [On incontinentia pigmenti and differentiation of two syndromes appearing under the same name.]. Dermatologica. Jan 1954;108(1):1-28. [Medline].
Frenk E, Mevorah B, Hohl D. The Nageli-Franceschetti-Jadassohn syndrome: A hereditary ectodermal defect leading to colloid-amyloid formation in the dermis. Dermatology. 1993;187(3):169-73. [Medline].
Froelich S, Houlden H, Rizzu P, et al. Construction of a detailed physical and transcript map of the FTDP-17 candidate region on chromosome 17q21. Genomics. Sep 1 1999;60(2):129-36. [Medline].
Fulk CS. Primary disorders of hyperpigmentation. J Am Acad Dermatol. Jan 1984;10(1):1-16. [Medline].
Griffiths WA. Reticulate pigmentary disorders--a review. Clin Exp Dermatol. Sep 1984;9(5):439-50. [Medline].
Heimer WL 2nd, Brauner G, James WD. Dermatopathia pigmentosa reticularis: a report of a family demonstrating autosomal dominant inheritance. J Am Acad Dermatol. Feb 1992;26(2 Pt 2):298-301. [Medline].
Itin PH, Lautenschlager S, Meyer R, et al. Natural history of the Naegeli-Franceschetti-Jadassohn syndrome and further delineation of its clinical manifestations. J Am Acad Dermatol. Jun 1993;28(6):942-50. [Medline].
Kitamura K, Hirako T. [Two Japanese cases of a peculiar reticulous pigmentation.]. Dermatologica. Feb 1955;110(2):97-107. [Medline].
Kudo Y, Fujiwara S, Takayasu S, et al. Reticulate pigmentary dermatosis associated with hypohydrosis and short stature: a variant of Naegeli-Franceschetti-Jadassohn syndrome?. Int J Dermatol. Jan 1995;34(1):30-1. [Medline].
Larregue M, Prigent F, Lorette G, et al. [Bullous and hereditary Weary-Kindler''s acrokeratotic poikiloderma (author''s transl)]. Ann Dermatol Venereol. 1981;108(1):69-76. [Medline].
Levi L, Galbiati G, Ghislanzoni G. [Reticular pigmentary dermatitis of Franceschetti-Jadassohn syndrome. Case report]. G Ital Dermatol Minerva Dermatol. Jul 1971;46(7):319-22. [Medline].
Lugassy J, Itin P, Ishida-Yamamoto A, et al. Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet. Oct 2006;79(4):724-30. [Medline].
Margolis B, Silvennoinen O, Comoglio F, et al. High-efficiency expression/cloning of epidermal growth factor-receptor- binding proteins with Src homology 2 domains. Proc Natl Acad Sci U S A. Oct 1 1992;89(19):8894-8. [Medline].
Maso MJ, Schwartz RA, Lambert WC. Dermatopathia pigmentosa reticularis. Arch Dermatol. Jul 1990;126(7):935-9. [Medline].
Mevorah B, Frascarolo P, Gianadda E, Donatsch J. Sweat studies under conditions of moderate heat stress in two patients with the Nageli-Franceschetti-Jadassohn syndrome. Dermatology. 1993;187(3):174-7. [Medline].
Naegeli O. Familiarer Chromnatophotennes. Schweiz Med Wochenschr. 1927;8:48.
Papini M. Sindrome di Naegeli-Franceschetti-Jadassohn. Ann Ital Dermatol Clin Sper. 1978;32:281-292.
Rebora A, Crovato F. The spectrum of Dowling-Degos disease. Br J Dermatol. May 1984;110(5):627-30. [Medline].
Schnur RE, Heymann WR. Reticulate hyperpigmentation. Semin Cutan Med Surg. Mar 1997;16(1):72-80. [Medline].
Sparrow GP, Samman PD, Wells RS. Hyperpigmentation and hypohidrosis. (The Naegeli-Franceschetti- Jadassohn syndrome): report of a family and review of the literature. Clin Exp Dermatol. Jun 1976;1(2):127-40. [Medline].
Tidman MJ, Wells RS, MacDonald DM. Pachyonychia congenita with cutaneous amyloidosis and hyperpigmentation- -a distinct variant. J Am Acad Dermatol. May 1987;16(5 Pt 1):935-40. [Medline].
Tzermias C, Zioga A, Hatzis I. Reticular pigmented genodermatosis with milia--a special form of Naegeli-Franceschetti-Jadassohn syndrome or a new entity?. Clin Exp Dermatol. Jul 1995;20(4):331-5. [Medline].
Whiting DA. Naegeli´s reticular pigmented dermatosis. Br J Dermatol. 1971;85:71-73.
Whittock NV, Coleman CM, McLean WH, et al. The gene for Naegeli-Franceschetti-Jadassohn syndrome maps to 17q21. J Invest Dermatol. Oct 2000;115(4):694-8. [Medline].
Zhao Z, Lee CC, Baldini A, Caskey CT. A human homologue of the Drosophila polarity gene frizzled has been identified and mapped to 17q21.1. Genomics. May 20 1995;27(2):370-3. [Medline].
Zillikens D, Mehringer A, Lechner W, Burg G. Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol. Feb 1991;13(1):57-62. [Medline].
Zinsser F. Atrophia curis reticularis cum pigmentatione, dystrophia et leukoplakia oris. Ikonogr Dermat. 1910;5:219-223.
NFJ syndrome, MIM 161000, reticulate pigmentary disorders, ectodermal dysplasia, hyperpigmentation, hypohidrosis, palmoplantar keratoderma
Ulrich Hengge, MD, MBA, Professor, Department of Dermatology, Heinrich-Heine-University Düsseldorf, Germany
Ulrich Hengge, MD, MBA is a member of the following medical societies: American Society of Gene Therapy and Society for Investigative Dermatology
Disclosure: Nothing to disclose.
Theo Rufli, MD, Professor of Dermatology and Venereology, Chair, Department of Dermatology, University Hospital of Basle, Switzerland
Disclosure: Nothing to disclose.
Peter Itin, MD, Associate Professor, Dermatology University Clinic, Switzerland
Peter Itin, MD is a member of the following medical societies: American Society of Tropical Medicine and Hygiene
Disclosure: Nothing to disclose.
James Fulton Jr, MD, PhD, Medical Director, Fulton Skin Institute
James Fulton Jr, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Cosmetic Surgery, American Academy of Dermatology, Phi Beta Kappa, and Sigma Xi
Disclosure: Nothing to disclose.
David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other
Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.
Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.
Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)